Skip to main content
Top
Published in: Heart and Vessels 4/2020

01-04-2020 | Stroke | Original Article

Ischemic stroke risk during post-discharge phases of heart failure: association of left ventricular concentric geometry

Authors: Yasuhiro Shintani, Hiroyuki Takahama, Yasuhiro Hamatani, Kunihiro Nishimura, Hideaki Kanzaki, Kengo Kusano, Teruo Noguchi, Kazunori Toyoda, Satoshi Yasuda, Chisato Izumi

Published in: Heart and Vessels | Issue 4/2020

Login to get access

Abstract

Despite a higher risk of ischemic stroke in hospitalized patients with acute heart failure (HF), little is known about the risk of ischemic stroke during the post-discharge phases of HF. Here we investigated (1) the ischemic stroke incidence rate during the post-discharge phases among HF patients receiving standard treatments; (2) the association between ischemic stroke incidence and clinical background, including cardiac structure and function. Among 950 patients who required hospitalization for HF (median duration: 19 days) at our institution, where they received standard treatments, we investigated stroke occurrences during the 2-year period following their discharge and retrospectively evaluated their clinical data. Relative wall thickness (RWT) and left ventricular (LV) mass were determined based on echocardiographic measurements and then used to determine LV geometric patterns. During the follow-up period, ischemic stroke occurred in 25 patients (2.6%) after hospital discharge (1.4 per 100 patient-years). The incidence rate of IS tended to be higher in patients with AF than those without AF (1.8 vs. 1.0 per 100 patient-years, respectively). Notably, multivariate analysis revealed a significant association between RWT and ischemic stroke risk (p < 0.05). RWT was associated with ischemic stroke risk in patients with AF or left atrial enlargement, but not in patients without them. These findings suggest that even with standard HF treatments, the risk of ischemic stroke is high in patients with HF. Moreover, LV concentric geometry is a significant risk factor for ischemic stroke in patients with HF, especially in those with left atrial remodeling and/or AF.
Literature
1.
go back to reference Adelborg K, Szepligeti S, Sundboll J, Horvath-Puho E, Henderson VW, Ording A, Pedersen L, Sorensen HT (2017) Risk of stroke in patients with heart failure: A population-based 30-year cohort study. Stroke 48:1161–1168CrossRef Adelborg K, Szepligeti S, Sundboll J, Horvath-Puho E, Henderson VW, Ording A, Pedersen L, Sorensen HT (2017) Risk of stroke in patients with heart failure: A population-based 30-year cohort study. Stroke 48:1161–1168CrossRef
2.
go back to reference Alberts VP, Bos MJ, Koudstaal P, Hofman A, Witteman JC, Stricker B, Breteler M (2010) Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol 25:807–812CrossRef Alberts VP, Bos MJ, Koudstaal P, Hofman A, Witteman JC, Stricker B, Breteler M (2010) Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol 25:807–812CrossRef
3.
go back to reference Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL (2006) Ischemic stroke after heart failure: a community-based study. Am Heart J 152:102–109CrossRef Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Ballman KV, Meverden RA, Roger VL (2006) Ischemic stroke after heart failure: a community-based study. Am Heart J 152:102–109CrossRef
4.
go back to reference Hamatani Y, Nagai T, Nakai M, Nishimura K, Honda Y, Nakano H, Honda S, Iwakami N, Sugano Y, Asaumi Y, Aiba T, Noguchi T, Kusano K, Toyoda K, Yasuda S, Yokoyama H, Ogawa H, Anzai T (2018) Elevated plasma d-dimer level is associated with short-term risk of ischemic stroke in patients with acute heart failure. Stroke 49:1737–1740CrossRef Hamatani Y, Nagai T, Nakai M, Nishimura K, Honda Y, Nakano H, Honda S, Iwakami N, Sugano Y, Asaumi Y, Aiba T, Noguchi T, Kusano K, Toyoda K, Yasuda S, Yokoyama H, Ogawa H, Anzai T (2018) Elevated plasma d-dimer level is associated with short-term risk of ischemic stroke in patients with acute heart failure. Stroke 49:1737–1740CrossRef
5.
go back to reference Iguchi M, Tezuka Y, Ogawa H, Hamatani Y, Takagi D, An Y, Unoki T, Ishii M, Masunaga N, Esato M, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M (2018) Incidence and risk factors of stroke or systemic embolism in patients with atrial fibrillation and heart failure—the Fushimi AF Registry. Circ J 82:1327–1335CrossRef Iguchi M, Tezuka Y, Ogawa H, Hamatani Y, Takagi D, An Y, Unoki T, Ishii M, Masunaga N, Esato M, Tsuji H, Wada H, Hasegawa K, Abe M, Lip GYH, Akao M (2018) Incidence and risk factors of stroke or systemic embolism in patients with atrial fibrillation and heart failure—the Fushimi AF Registry. Circ J 82:1327–1335CrossRef
6.
go back to reference Hamatani Y, Iguchi M, Nakamura M, Ohtani R, Yamashita Y, Takagi D, Unoki T, Ishii M, Masunaga N, Ogawa H, Hamatani M, Abe M, Akao M (2016) Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure. Heart Vessels 31:1154–1161CrossRef Hamatani Y, Iguchi M, Nakamura M, Ohtani R, Yamashita Y, Takagi D, Unoki T, Ishii M, Masunaga N, Ogawa H, Hamatani M, Abe M, Akao M (2016) Incidence and predictors of ischemic stroke during hospitalization for congestive heart failure. Heart Vessels 31:1154–1161CrossRef
7.
go back to reference Popovic B, Zannad F, Louis H, Clerc-Urmes I, Lakomy C, Gibot S, Denis CV, Lacolley P, Regnault V (2019) Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure. Int J Cardiol 274:195–201CrossRef Popovic B, Zannad F, Louis H, Clerc-Urmes I, Lakomy C, Gibot S, Denis CV, Lacolley P, Regnault V (2019) Endothelial-driven increase in plasma thrombin generation characterising a new hypercoagulable phenotype in acute heart failure. Int J Cardiol 274:195–201CrossRef
8.
go back to reference Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O'Connor CM (2013) Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol 167:1772–1782CrossRef Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O'Connor CM (2013) Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int J Cardiol 167:1772–1782CrossRef
9.
go back to reference Vaziri SM, Larson MG, Benjamin EJ, Levy D (1994) Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham heart study. Circulation 89:724–730CrossRef Vaziri SM, Larson MG, Benjamin EJ, Levy D (1994) Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham heart study. Circulation 89:724–730CrossRef
10.
go back to reference Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S (2003) Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 34:2380–2384CrossRef Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S (2003) Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 34:2380–2384CrossRef
11.
go back to reference Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL (2000) Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31:1081–1089CrossRef Lee LJ, Kidwell CS, Alger J, Starkman S, Saver JL (2000) Impact on stroke subtype diagnosis of early diffusion-weighted magnetic resonance imaging and magnetic resonance angiography. Stroke 31:1081–1089CrossRef
12.
go back to reference Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115CrossRef Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115CrossRef
13.
go back to reference Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM (2012) Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 5:710–719CrossRef Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM (2012) Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 5:710–719CrossRef
14.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200CrossRef
15.
go back to reference Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRef Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRef
16.
go back to reference Imazu M, Takahama H, Asanuma H, Funada A, Sugano Y, Ohara T, Hasegawa T, Asakura M, Kanzaki H, Anzai T, Kitakaze M (2014) Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease. Am J Physiol Heart Circ Physiol 307:H1504–H1511CrossRef Imazu M, Takahama H, Asanuma H, Funada A, Sugano Y, Ohara T, Hasegawa T, Asakura M, Kanzaki H, Anzai T, Kitakaze M (2014) Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease. Am J Physiol Heart Circ Physiol 307:H1504–H1511CrossRef
17.
go back to reference Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRef Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRef
18.
go back to reference Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E (2004) Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43:731–738CrossRef Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, Poisa P, Rizzoni D, Castellano M, Agabiti-Rosei E (2004) Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 43:731–738CrossRef
19.
go back to reference Misirli HC, Yanar HT, Erdogan SN, Akkilic EC, Ozkan D, Bayram T, Araz O (2015) Frequency of left atrial dilatation in ischemic stroke. North Clin Istanb 2:7–12PubMedPubMedCentral Misirli HC, Yanar HT, Erdogan SN, Akkilic EC, Ozkan D, Bayram T, Araz O (2015) Frequency of left atrial dilatation in ischemic stroke. North Clin Istanb 2:7–12PubMedPubMedCentral
20.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated gfr from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated gfr from serum creatinine in Japan. Am J Kidney Dis 53:982–992CrossRef
21.
go back to reference Takashima N, Arima H, Kita Y, Fujii T, Miyamatsu N, Komori M, Sugimoto Y, Nagata S, Miura K, Nozaki K (2017) Incidence, management and short-term outcome of stroke in a general population of 1.4 million Japanese–Shiga Stroke Registry. Circ J 81:1636–1646CrossRef Takashima N, Arima H, Kita Y, Fujii T, Miyamatsu N, Komori M, Sugimoto Y, Nagata S, Miura K, Nozaki K (2017) Incidence, management and short-term outcome of stroke in a general population of 1.4 million Japanese–Shiga Stroke Registry. Circ J 81:1636–1646CrossRef
22.
go back to reference Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ (2015) Risk of stroke in chronic heart failure patients without atrial fibrillation: Analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'insufficienza Cardiaca-Heart Failure (GISSI-HF) trials. Circulation 131:1486–1494CrossRef Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ (2015) Risk of stroke in chronic heart failure patients without atrial fibrillation: Analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'insufficienza Cardiaca-Heart Failure (GISSI-HF) trials. Circulation 131:1486–1494CrossRef
23.
go back to reference Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, McMurray JJV (2017) Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the charm-preserved and i-preserve trials. Eur Heart J 38:742–750PubMed Abdul-Rahim AH, Perez AC, MacIsaac RL, Jhund PS, Claggett BL, Carson PE, Komajda M, McKelvie RS, Zile MR, Swedberg K, Yusuf S, Pfeffer MA, Solomon SD, Lip GYH, Lees KR, McMurray JJV (2017) Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the charm-preserved and i-preserve trials. Eur Heart J 38:742–750PubMed
24.
go back to reference Erkuner O, Dudink E, Nieuwlaat R, Rienstra M, Van Gelder IC, Camm AJ, Capucci A, Breithardt G, LeHeuzey JY, Lip GYH, Crijns H, Luermans J (2018) Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey). Am J Cardiol 122:578–583CrossRef Erkuner O, Dudink E, Nieuwlaat R, Rienstra M, Van Gelder IC, Camm AJ, Capucci A, Breithardt G, LeHeuzey JY, Lip GYH, Crijns H, Luermans J (2018) Effect of systemic hypertension with versus without left ventricular hypertrophy on the progression of atrial fibrillation (from the Euro Heart Survey). Am J Cardiol 122:578–583CrossRef
25.
go back to reference Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, Inoko M (2018) Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep 8:6366CrossRef Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, Inoko M (2018) Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep 8:6366CrossRef
26.
go back to reference Iwakura K, Okamura A, Koyama Y, Date M, Higuchi Y, Inoue K, Kimura R, Nagai H, Toyoshima Y, Ozawa M, Ito N, Shibuya M, Omiya S, Takagi T, Morisawa D, Fujii K (2011) Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Am J Cardiol 107:417–422CrossRef Iwakura K, Okamura A, Koyama Y, Date M, Higuchi Y, Inoue K, Kimura R, Nagai H, Toyoshima Y, Ozawa M, Ito N, Shibuya M, Omiya S, Takagi T, Morisawa D, Fujii K (2011) Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Am J Cardiol 107:417–422CrossRef
27.
go back to reference Cioffi G, Mureddu GF, Stefenelli C, de Simone G (2004) Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens 22:1589–1596CrossRef Cioffi G, Mureddu GF, Stefenelli C, de Simone G (2004) Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension. J Hypertens 22:1589–1596CrossRef
28.
go back to reference Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted county, Minnesota. Circulation 115:1982–1990CrossRef Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, Kass DA, Redfield MM (2007) Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted county, Minnesota. Circulation 115:1982–1990CrossRef
29.
go back to reference Weitz JI, Fredenburgh JC, Eikelboom JW (2017) A test in context: D-dimer. J Am Coll Cardiol 70:2411–2420CrossRef Weitz JI, Fredenburgh JC, Eikelboom JW (2017) A test in context: D-dimer. J Am Coll Cardiol 70:2411–2420CrossRef
30.
go back to reference Chung I, Choudhury A, Lip GY (2007) Platelet activation in acute, decompensated congestive heart failure. Thromb Res 120:709–713CrossRef Chung I, Choudhury A, Lip GY (2007) Platelet activation in acute, decompensated congestive heart failure. Thromb Res 120:709–713CrossRef
31.
go back to reference Di Mascio R, Marchioli R, Vitullo F, Tognoni G (1996) A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3a investigators. Eur Neurol 36:85–88CrossRef Di Mascio R, Marchioli R, Vitullo F, Tognoni G (1996) A positive relation between high hemoglobin values and the risk of ischemic stroke. Progetto 3a investigators. Eur Neurol 36:85–88CrossRef
Metadata
Title
Ischemic stroke risk during post-discharge phases of heart failure: association of left ventricular concentric geometry
Authors
Yasuhiro Shintani
Hiroyuki Takahama
Yasuhiro Hamatani
Kunihiro Nishimura
Hideaki Kanzaki
Kengo Kusano
Teruo Noguchi
Kazunori Toyoda
Satoshi Yasuda
Chisato Izumi
Publication date
01-04-2020
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 4/2020
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01522-x

Other articles of this Issue 4/2020

Heart and Vessels 4/2020 Go to the issue